Annual FCF
-$8.07 M
+$1.54 M+16.02%
31 December 2023
Summary:
Processa Pharmaceuticals annual free cash flow is currently -$8.07 million, with the most recent change of +$1.54 million (+16.02%) on 31 December 2023. During the last 3 years, it has fallen by -$4.92 million (-156.62%). PCSA annual FCF is now -18571.53% below its all-time high of -$43.20 thousand, reached on 31 December 2016.PCSA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$3.61 M
-$260.10 K-7.77%
30 September 2024
Summary:
Processa Pharmaceuticals quarterly free cash flow is currently -$3.61 million, with the most recent change of -$260.10 thousand (-7.77%) on 30 September 2024. Over the past year, it has dropped by -$1.84 million (-104.45%). PCSA quarterly FCF is now -12448.97% below its all-time high of $29.20 thousand, reached on 30 September 2020.PCSA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$11.12 M
-$1.84 M-19.85%
30 September 2024
Summary:
Processa Pharmaceuticals TTM free cash flow is currently -$11.12 million, with the most recent change of -$1.84 million (-19.85%) on 30 September 2024. Over the past year, it has dropped by -$2.68 million (-31.81%). PCSA TTM FCF is now -202363.64% below its all-time high of $5500.00, reached on 31 March 2017.PCSA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCSA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.0% | -104.5% | -31.8% |
| 3 y3 years | -156.6% | -132.2% | -34.6% |
| 5 y5 years | -116.2% | -399.6% | -327.8% |
PCSA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -156.6% | +16.0% | -132.2% | at low | -39.0% | at low |
| 5 y | 5 years | -193.3% | +16.0% | <-9999.0% | at low | -651.0% | at low |
| alltime | all time | <-9999.0% | +16.0% | <-9999.0% | at low | <-9999.0% | at low |
Processa Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.61 M(+7.8%) | -$11.12 M(+19.8%) |
| June 2024 | - | -$3.35 M(+63.3%) | -$9.28 M(+16.0%) |
| Mar 2024 | - | -$2.05 M(-3.5%) | -$8.00 M(-0.8%) |
| Dec 2023 | -$8.07 M(-16.0%) | -$2.12 M(+20.4%) | -$8.07 M(-4.4%) |
| Sept 2023 | - | -$1.76 M(-14.6%) | -$8.44 M(-12.5%) |
| June 2023 | - | -$2.06 M(-2.3%) | -$9.65 M(-2.7%) |
| Mar 2023 | - | -$2.11 M(-15.3%) | -$9.92 M(+3.2%) |
| Dec 2022 | -$9.61 M(+10.2%) | -$2.50 M(-16.0%) | -$9.61 M(-2.3%) |
| Sept 2022 | - | -$2.97 M(+27.6%) | -$9.83 M(+16.9%) |
| June 2022 | - | -$2.33 M(+29.3%) | -$8.41 M(+1.6%) |
| Mar 2022 | - | -$1.80 M(-33.9%) | -$8.28 M(-5.1%) |
| Dec 2021 | -$8.72 M(+177.3%) | -$2.73 M(+75.6%) | -$8.72 M(+5.5%) |
| Sept 2021 | - | -$1.55 M(-29.2%) | -$8.27 M(+23.7%) |
| June 2021 | - | -$2.19 M(-2.2%) | -$6.68 M(+38.1%) |
| Mar 2021 | - | -$2.24 M(-1.4%) | -$4.84 M(+54.0%) |
| Dec 2020 | -$3.14 M(+14.3%) | -$2.28 M(-7892.5%) | -$3.14 M(+112.2%) |
| Sept 2020 | - | $29.20 K(-108.3%) | -$1.48 M(-33.6%) |
| June 2020 | - | -$350.60 K(-35.8%) | -$2.23 M(-17.0%) |
| Mar 2020 | - | -$546.50 K(-10.9%) | -$2.69 M(-2.2%) |
| Dec 2019 | -$2.75 M(-26.3%) | -$613.50 K(-15.0%) | -$2.75 M(+5.7%) |
| Sept 2019 | - | -$721.80 K(-10.6%) | -$2.60 M(-10.6%) |
| June 2019 | - | -$807.50 K(+32.9%) | -$2.91 M(-10.9%) |
| Mar 2019 | - | -$607.40 K(+30.9%) | -$3.27 M(-12.4%) |
| Dec 2018 | -$3.73 M | -$464.00 K(-55.0%) | -$3.73 M(-20.1%) |
| Sept 2018 | - | -$1.03 M(-11.4%) | -$4.67 M(+22.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$1.16 M(+8.7%) | -$3.81 M(+40.0%) |
| Mar 2018 | - | -$1.07 M(-23.8%) | -$2.72 M(+64.6%) |
| Dec 2017 | -$1.68 M(+3777.8%) | -$1.40 M(+708.6%) | -$1.65 M(+543.8%) |
| Sept 2017 | - | -$173.70 K(+132.5%) | -$257.00 K(+285.9%) |
| June 2017 | - | -$74.70 K(+4568.8%) | -$66.60 K(-1310.9%) |
| Mar 2017 | - | -$1600.00(-77.1%) | $5500.00(-112.7%) |
| Dec 2016 | -$43.20 K(-95.1%) | -$7000.00(-141.9%) | -$43.30 K(-47.5%) |
| Sept 2016 | - | $16.70 K(-742.3%) | -$82.40 K(-43.7%) |
| June 2016 | - | -$2600.00(-94.8%) | -$146.30 K(-65.2%) |
| Mar 2016 | - | -$50.40 K(+9.3%) | -$420.20 K(-51.9%) |
| Dec 2015 | -$873.30 K(-67.7%) | -$46.10 K(-2.3%) | -$873.30 K(-31.1%) |
| Sept 2015 | - | -$47.20 K(-82.9%) | -$1.27 M(-28.4%) |
| June 2015 | - | -$276.50 K(-45.1%) | -$1.77 M(-19.7%) |
| Mar 2015 | - | -$503.50 K(+14.2%) | -$2.20 M(-18.4%) |
| Dec 2014 | -$2.70 M(+5.3%) | -$440.90 K(-19.9%) | -$2.70 M(-0.8%) |
| Sept 2014 | - | -$550.20 K(-22.5%) | -$2.72 M(-6.2%) |
| June 2014 | - | -$710.10 K(-29.1%) | -$2.90 M(-2.2%) |
| Mar 2014 | - | -$1.00 M(+116.5%) | -$2.97 M(+15.7%) |
| Dec 2013 | -$2.57 M(+15.3%) | -$462.50 K(-36.6%) | -$2.57 M(-7.2%) |
| Sept 2013 | - | -$729.70 K(-5.8%) | -$2.77 M(-5.8%) |
| June 2013 | - | -$775.00 K(+29.3%) | -$2.94 M(+11.7%) |
| Mar 2013 | - | -$599.20 K(-9.5%) | -$2.63 M(+18.1%) |
| Dec 2012 | -$2.23 M | -$662.20 K(-26.5%) | -$2.23 M(+42.3%) |
| Sept 2012 | - | -$900.50 K(+92.5%) | -$1.56 M(+135.6%) |
| June 2012 | - | -$467.90 K(+138.5%) | -$664.10 K(+238.5%) |
| Mar 2012 | - | -$196.20 K | -$196.20 K |
FAQ
- What is Processa Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual FCF year-on-year change?
- What is Processa Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly FCF year-on-year change?
- What is Processa Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals TTM FCF year-on-year change?
What is Processa Pharmaceuticals annual free cash flow?
The current annual FCF of PCSA is -$8.07 M
What is the all time high annual FCF for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual free cash flow is -$43.20 K
What is Processa Pharmaceuticals annual FCF year-on-year change?
Over the past year, PCSA annual free cash flow has changed by +$1.54 M (+16.02%)
What is Processa Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of PCSA is -$3.61 M
What is the all time high quarterly FCF for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly free cash flow is $29.20 K
What is Processa Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, PCSA quarterly free cash flow has changed by -$1.84 M (-104.45%)
What is Processa Pharmaceuticals TTM free cash flow?
The current TTM FCF of PCSA is -$11.12 M
What is the all time high TTM FCF for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high TTM free cash flow is $5500.00
What is Processa Pharmaceuticals TTM FCF year-on-year change?
Over the past year, PCSA TTM free cash flow has changed by -$2.68 M (-31.81%)